What is the Buying Price of Aarti Pharmalabs Share?

The Buying Price of Aarti Pharmalabs share is 635.2 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.

How to buy Aarti Pharmalabs Share at Choice?

To buy Aarti Pharmalabs stocks , log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Aarti Pharmalabs, choose your preferred order type, and place the trade.

What is the PE ratio of Aarti Pharmalabs Shares?

The Price-to-earnings (P/E) ratio of Aarti Pharmalabs shares is 33.34. You can compare it with the sector average for relative valuation.

What is the PB ratio of Aarti Pharmalabs Shares?

The Price to Book (P/B) ratio Aarti Pharmalabs shares is 2.74. Useful to assess the stock's value relative to its book value.

Is Aarti Pharmalabs Overvalued?

To assess Aarti Pharmalabs’s valuation compare Sector P/E, P/B which are 69.94 & 2.97 with sector averages, along with growth rates and financial metrics.

What is the Market Cap of Aarti Pharmalabs?

The Market Cap of Aarti Pharmalabs is 5758.58 CR. It indicates the company's size category and trading liquidity.

What is the 52 Week High and Low of Aarti Pharmalabs Share Price?

The 52 week high and low prices of Aarti Pharmalabs share price is 971 & 585. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.

Which sector does Aarti Pharmalabs belong to?

Aarti Pharmalabs belongs to the Healthcare sector.

Aarti Pharmalabs Share price

AARTIPHARM

Healthcare Mid Cap

635.2

7.15 (-1.11%)

NSE

BSE

Last updated on 2 Jun, 2026 | 15:51 IST

BUYSELL

Today's High

646.90

Today's Low

628.15

52 Week Low

585.00

52 Week High

971.00

Free Demat with Zero AMC*

Aarti Pharmalabs Chart

ChartIQ

TradingView

Aarti Pharmalabs Share Key Metrics

Volume

1.73 L

Market Cap

5758.58 CR

LTQ@LTP

112@635.20

ATP

636.92 Var Margin

21.46 %

Circuit Range

513.9-770.8

Delivery %

43.61 %

Value

10.99 CR

ASM/GSM

No

Market Lot

1

Summary

2 Jun, 2026 | 15:51 को, Aarti Pharmalabs का शेयर प्राइस आज ₹635.2 पर है, जो दिन के लिए 7.15% की -1.11 दर्शाता है। स्टॉक की इंट्राडे मूवमेंट ₹628.15 और ₹646.90 के बीच रही है, जबकि 52‑सप्ताह के आधार पर यह ₹585.00 से ₹971.00 तक रही है। ट्रेडिंग गतिविधि के मामले में, Aarti Pharmalabs ने 172574 शेयरों का वॉल्यूम रिकॉर्ड किया है, जिसका मार्केट कैपिटलाइज़ेशन ₹90657751 है। स्टॉक की एवरेज ट्रेडेड प्राइस ₹63692 है, जबकि लास्ट ट्रेडेड क्वांटिटी एट लास्ट ट्रेडेड प्राइस (LTQ@LTP) 112,63520 रही। यह स्टॉक ₹513.9-770.8 की सर्किट रेंज में ट्रेड करता है, और आज का कारोबार मूल्य ₹10.99 CR है। दिन के लिए डिलीवरी परसेंटेज 43.61% रही। इसके अतिरिक्त, Aarti Pharmalabs वर्तमान में No फ्रेमवर्क के तहत आता है और 1 के मार्केट लॉट साइज़ में ट्रेड करता

Aarti Pharmalabs Fundamentals

P/E Ratio

33.34

P/B Ratio

2.74

Div. Yield

0.54

Sector P/E

69.94

Sector P/B

2.97

Sec. Div. Yield

0.55

Aarti Pharmalabs Resistance and Support

Pivot 645.68

Resistance

First Resistance

656.36

Second Resistance

670.38

Third Resistance

681.06

Support

First Support

631.66

Second Support

620.98

Third Support

606.96

Aarti Pharmalabs Shareholding Pattern

2023-24
2024-25
2025-26
2026-27

Total Promoters

Segment

Percent

Total Promoters

44.66%

Mutual Fund

3.93%

Insurance

6.09%

Foreign Institutional Investors

8.64%

Domestic Institutional Investors

0.35%

Retail

36.33%

Others

0%

Total Promoters

MAR '24

46.46%

JUN '24

46.46%

SEP '24

46.1%

DEC '24

44.66%

Aarti Pharmalabs Corporate Actions

Date	Agenda
2026-05-25	Audited Results & Final Dividend
2026-05-18	Audited Results & Final Dividend
2026-02-09	Quarterly Results & Interim Dividend

Aarti Pharmalabs News

Aarti Pharmalabs Ltd - 543748 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

Aarti Pharma Labs has made available the audio recording of its Investors/Analyst Earnings Conference Call for the fourth quarter and financial year ended March 31, 2026. The recording can be accessed on the company's website.

May 26 2026 22:14:06

Aarti Pharmalabs Ltd - 543748 - Re-Appointment Of Cost Auditor & Internal Auditor For FY 2026-2027

Aarti Pharma Labs board meeting outcomes include approval of Q4 and FY26 financial results, recommendation of a final dividend of Rs.2 per equity share, and the re-appointment of cost and internal auditors for FY26-27.

May 25 2026 21:13:46

Aarti Pharmalabs Ltd - 543748 - Corporate Action-Board to consider Dividend

Aarti Pharma Labs declared a final dividend of ₹2 per equity share for FY26. This payout, representing 40% of face value, is contingent on shareholder approval at the AGM.

May 25 2026 21:11:16

Aarti Pharmalabs Ltd - 543748 - Board Meeting Outcome for Approval Of Audited Standalone And Consolidated Financial Results For The Quarter And Financial Year Ended On 31 March 2026 And Recommending Final Dividend.

Aarti Pharma Labs' board approved audited consolidated FY26 financial results, reporting revenue of ₹1,819.44 cr and net profit of ₹174.71 cr. The board also recommended a final dividend of ₹2 per share for FY26 and re-appointed its cost and internal auditors for FY27.

May 25 2026 21:07:34

Aarti Pharmalabs Ltd - 543748 - Update on board meeting

Aarti Pharma Labs has rescheduled its board meeting for Q4 FY26 financial results. The meeting will now be held on May 25, 2026, instead of the previously scheduled May 18, 2026, to consider the financial performance for the quarter and year ended March 31, 2026.

May 14 2026 11:26:29

Aarti Pharmalabs Ltd - 543748 - Board Meeting Intimation for Approval Of The Audited Financial Results For The Quarter And Financial Year Ended March 31, 2026 And Recommendation Of Final Dividend, If Any.

Aarti Pharma Labs' Board of Directors will meet on May 18, 2026, to consider and approve the audited financial results for the quarter and financial year ended March 31, 2026. They will also consider and recommend a final dividend for FY26.

May 11 2026 15:09:29

Name	Position
Jeevan Mondkar	Company Secretary
Chandrakant V Gogri	Chairman Emeritus

Aarti Pharmalabs Similar Stocks

Suven Life Sciences Ltd.

275.20

0.35 (0.13%)

Sanofi India Ltd.

3169.20

51.60 (1.66%)

FDC Ltd.

392.75

-2.40 (0.61%)

Nephrocare Health Services Ltd.

660.45

23.85 (3.75%)

Kovai Medical Center & Hospital Ltd.

5342.00

-27.50 (0.51%)

Senores Pharmaceuticals Ltd.

1033.50

-34.30 (3.21%)

Supriya Lifescience Ltd.

917.25

-135.25 (12.85%)

Innova Captab Ltd.

862.40

1.60 (0.19%)

Bliss GVS Pharma Ltd.

434.45

32.00 (7.95%)

Artemis Medicare Services Ltd.

270.90

3.30 (1.23%)

Aarti Pharmalabs FAQs

Aarti Pharmalabs शेयर का खरीद मूल्य 635.2 है। लाइव प्राइस और तत्काल ट्रेडिंग के लिए, आप अपने चॉइस ट्रेडिंग खाते में लॉगिन कर सकते हैं या चॉइस के साथ मुक्त डीमैट खाता खोल सकते हैं।

Aarti Pharmalabs शेयर खरीदने के लिए अपने चॉइस ट्रेडिंग खाते में लॉगिन करें, या चॉइस डीमैट खाता खोल, फिर फंड जोड़ें, कंपनी का नाम खोजें, अपना ऑर्डर टाइप चुनें और ट्रेड प्लेस करें।

Aarti Pharmalabs शेयर का प्राइस-टू-अर्निंग्स (पी/ई) रेशियो 33.34 है। आप सापेक्ष मूल्यांकन के लिए इसकी तुलना सेक्टर के औसत से कर सकते हैं।

Aarti Pharmalabs शेयर का प्राइस-टू-बुक (पी/बी) रेशियो 2.74 है। यह शेयर के मूल्य की तुलना उसकी बुक वैल्यू से करने में उपयोगी है।

Aarti Pharmalabs शेयर का प्राइस-टू-बुक (पी/बी) रेशियो 2.97 है। यह शेयर के मूल्य की तुलना उसकी बुक वैल्यू से करने में उपयोगी है।

Aarti Pharmalabs का मार्केट कैप 5758.58 CR है। यह कंपनी के आकार की श्रेणी और ट्रेडिंग लिक्विडिटी को दर्शाता है।

Aarti Pharmalabs शेयर का 52 सप्ताह का उच्चतम और न्यूनतम मूल्य 971.00 और 585.00 है। ये मूल्य मूल्य सीमाएं, ट्रेडिंग रेंज, अस्थिरता, संभावित सपोर्ट/रेजिस्टेंस और मूल्य गति को दर्शाते हैं।